Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Non Operating Income (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Non Operating Income for 5 consecutive years, with -$83000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Non Operating Income fell 116.18% to -$83000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was -$205000.0, a 4000.0% decrease, with the full-year FY2024 number at -$190000.0, down 66.67% from a year prior.
  • Non Operating Income was -$83000.0 for Q4 2020 at Forte Biosciences, up from -$92000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $513000.0 in Q4 2019 to a low of -$762000.0 in Q2 2018.
  • A 5-year average of -$207764.7 and a median of -$213000.0 in 2019 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: skyrocketed 98.01% in 2019, then tumbled 1433.33% in 2020.
  • Forte Biosciences' Non Operating Income stood at -$456000.0 in 2016, then surged by 67.11% to -$150000.0 in 2017, then crashed by 100.67% to -$301000.0 in 2018, then skyrocketed by 270.43% to $513000.0 in 2019, then tumbled by 116.18% to -$83000.0 in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Non Operating Income are -$83000.0 (Q4 2020), -$92000.0 (Q3 2020), and -$7000.0 (Q2 2020).